Cell Culture Technology– category –
-
Biomanufacturing Reorients: Geopolitical Forces Drive Sourcing to Qualified, Regional Capacity, with Cellares Pioneering IDMO Smart Factories
Pharma's Almanac USA Overview Geopolitical forces are profoundly reshaping biomanufacturing procurement, driving a surge in demand for 'qualified capacity' – providers with specialized expertise and robust regulatory compliance. This shi... -
Cracking the Cost Code: Cellares’ Automated Platform Targets 75% Reduction in CAR-T Manufacturing, Pinpointing Viral Vectors as Key Driver
IntuitionLabs USA Overview A new analysis highlights viral vectors as the primary cost driver in CAR-T cell therapy manufacturing, prompting an urgent need for more efficient production. While existing closed-system platforms offer incre... -
Cell Therapy Consumables Market Set for $7.53 Billion Surge by 2032, Fueled by Automation and Closed Systems
Credence Research India Overview A new report from Credence Research projects the global cell therapy consumables market will reach $7.53 billion by 2032. This significant growth is primarily driven by the expanding adoption of advanced ... -
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
Miltenyi Biotec’s CliniMACS Prodigy® Automates TIL Expansion, Paving Way for Scalable Cancer Immunotherapy
Bioprocess Online Germany Overview Miltenyi Biotec is advancing the automated expansion of tumor-infiltrating lymphocytes (TILs) using its GMP-compliant CliniMACS Prodigy® platform. This system addresses critical challenges in scaling up... -
Allogeneic Cell Therapy Manufacturing: Broad Applicability, Scalability, and Automation Driving Future Advances
Industry Informational Article USA Overview This article provides a comprehensive overview of allogeneic cell therapy manufacturing, highlighting its advantages over autologous approaches, including broader applicability, superior scalab... -
Liv Hospital Highlights Off-the-Shelf Allogeneic CAR-T Manufacturing for Enhanced Accessibility via Standardized Donor Cells
Liv Hospital Turkey Overview Liv Hospital is championing the development of allogeneic CAR-T cell manufacturing as an 'off-the-shelf' solution, leveraging standardized donor cells to significantly improve treatment accessibility. This ad... -
Scaling the Future of Medicine: RoosterBio and Applied StemCell Partner on iPSC Bioprocess Solutions
PRNewswire USA Overview RoosterBio and Applied StemCell have announced a strategic partnership aimed at advancing scalable induced pluripotent stem cell (iPSC)-based bioprocess solutions. This collaboration integrates Applied StemCell's ... -
CDMOs Accelerate GLP-1 Manufacturing, Outpacing Traditional Facility Builds to Meet Soaring Demand
Pharma Advancement USA Overview Contract Development and Manufacturing Organizations (CDMOs) are rapidly scaling their manufacturing capabilities for GLP-1 receptor agonists, providing quicker solutions than ground-up facility constructi... -
July 2026 Pharma M&A Review Highlights Manufacturing Partnerships and AI Innovation as Key Trends, Featuring Major Investments by Lonza, AGC Biologics, and Evonik
Biospectrum Jobs India Overview A July 2026 review of pharmaceutical M&A activities identifies manufacturing partnerships and AI innovation as critical emerging trends. Key players like Lonza expanded biopharmaceutical alliances, AGC...
